Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years — India, 2014 and updates on immunization

• Published in: Indian pediatrics Vol. 51; no. 10; pp. 785 - 800
• Main Authors: Vashishtha, Vipin M., Choudhury, Panna, Kalra, Ajay, Bose, Anuradha, Thacker, Naveen, Yewale, Vijay N., Bansal, C. P., Mehta, Pravin J.
• Format: Journal Article
• Language: English
• Published: India Springer India 01.10.2014
• Subjects: Adolescent; Child; Child, Preschool; Female; Guidelines; Humans; Immunization Schedule; Infant; Male; Maternal and Child Health; Medicine; Medicine & Public Health; Pediatric Surgery; Pediatrics; Vaccines - administration & dosage; Immunity; Child; MMR Vaccine; Vaccination; Guidelines
• ISSN: 0019-6061; 0974-7559
• DOI: 10.1007/s13312-014-0504-y

Justification There is a need to review/revise recommendations about existing vaccines in light of recent developments in the field of vaccinology. Process Following an IAP ACVIP meeting on April 19 and 20, 2014, a draft of revised recommendations for the year 2014 and updates on certain vaccine formulations was prepared and circulated among the meeting participants to arrive at a consensus. Objectives To review and revise recommendations for 2014 Immunization timetable for pediatricians in office practice and issue statements on certain new and existing vaccine formulations. Recommendations The major changes in the 2014 Immunization Timetable include two doses of MMR vaccine at 9 and 15 months of age, single dose recommendation for administration of live attenuated H2 strain hepatitis A vaccine, inclusion of two new situations in ‘high-risk category of children’ in context with ‘pre-exposure prophylaxis’ of rabies, creation of a new slot at 9–12 months of age for typhoid conjugate vaccine for primary immunization, and recommendation of two doses of human papilloma virus vaccines with a minimum interval of 6 months between doses for primary schedule of adolescent/preadolescent girls aged 9–14 years. There would not be any change to the committee’s last year’s (2013) recommendations on pertussis vaccination and administration schedule of monovalent human rotavirus vaccine. There is no need of providing additional doses of whole-cell pertussis vaccine to children who have earlier completed their primary schedule with acellular pertussis vaccine-containing products. A brief update on the new Indian Rotavirus vaccine, 116E is also provided. The committee has reviewed and offered its recommendations on the currently available pentavalent vaccine (DTwP+Hib+Hepatitis-B) combinations in Indian market. The comments and footnotes for several vaccines are also updated and revised.